RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31678166http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31678166http://www.w3.org/2000/01/rdf-schema#comment"The therapy resistance of pancreatic cancer is associated with the loss of gap junction intercellular communication and connexin 43 expression. The broccoli isothiocyanate sulforaphane restored these features and therapy sensitivity. We investigated whether microRNA signaling is involved. Established cell lines and a patient tissue array (n = 96) were evaluated by miRNA and gene array, bioinformatics, expression studies, in situ hybridization and immunohistochemistry. Sulforaphane inhibited the expression of our top candidate miR30a-3p. Upon transfection of miR30a-3p inhibitors, the gemcitabine bystander effect, Cx43 expression and intercellular communication increased, whereas miR30a-3p mimics inhibited the luciferase activity of a Cx43 3'-UTR construct. miR30a-3p-overexpressing tumor xenografts had a decreased tumor volume and increased gemcitabine sensitivity. In patient tissues, a higher expression of miR30a-3p and a lower expression of Cx43 correlated with malignancy. These findings provide new knowledge and suggest sulforaphane as cotreatment for pancreatic cancer."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.org/dc/terms/identifier"doi:10.1016/j.canlet.2019.10.042"xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Gross W."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Xiao X."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Yin L."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Gretz N."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Schafer M."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Sticht C."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Torre C."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Herr I."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Karakhanova S."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Gladkich J."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/author"Georgikou C."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/name"Cancer Lett"xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/pages"238-245"xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/title"Inhibition of miR30a-3p by sulforaphane enhances gap junction intercellular communication in pancreatic cancer."xsd:string
http://purl.uniprot.org/citations/31678166http://purl.uniprot.org/core/volume"469"xsd:string
http://purl.uniprot.org/citations/31678166http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31678166
http://purl.uniprot.org/citations/31678166http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31678166
http://purl.uniprot.org/uniprot/#_A0A654IBU3-mappedCitation-31678166http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31678166
http://purl.uniprot.org/uniprot/#_B4DGM6-mappedCitation-31678166http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31678166
http://purl.uniprot.org/uniprot/#_B4DI81-mappedCitation-31678166http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31678166
http://purl.uniprot.org/uniprot/#_B4DMC9-mappedCitation-31678166http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31678166